<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="31822">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02692417</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00101713</org_study_id>
    <nct_id>NCT02692417</nct_id>
  </id_info>
  <brief_title>Surface Stimulation for Female Sexual Dysfunction</brief_title>
  <official_title>Surface Stimulation for Female Sexual Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Timothy Bruns</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Female sexual dysfunction, including sexual arousal disorder, has a significant clinical
      impact, affecting millions of women in the United States alone. Peripheral nerve
      stimulation, such as posterior tibial nerve stimulation (PTNS) and dorsal genital nerve
      stimulation (DGNS) can modulate neural circuits for bladder and fecal continence. The
      investigators hypothesize that periodic DGNS and PTNS will modulate autonomic neural
      circuits and promote improvements in sexual function in women with sexual arousal disorder.
      Subjects will be randomized to receive one of the stimulation approaches. Subjects will have
      weekly 30-minute sessions across twelve weeks.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in Female Sexual Function Index (FSFI)</measure>
    <time_frame>6, 12, and 18 weeks after beginning of treatment</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Female Sexual Dysfunction</condition>
  <arm_group>
    <arm_group_label>Posterior Tibial Nerve Stimulation Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in this group will have transcutaneous electrical nerve stimulation electrodes placed on the skin surface over their posterior tibial nerve, that is in the area of the ankle, and receive stimulation for 30 minutes in weekly sessions for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dorsal Genital Nerve Stimulation Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in this group will have transcutaneous electrical nerve stimulation electrodes placed on the skin surface over the dorsal genital nerve, that is above and/or on the lateral side of the clitoris, and receive stimulation for 30 minutes in weekly sessions for 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous Electrical Nerve Stimulation</intervention_name>
    <description>Both arms will receive stimulation from the same TENS (transcutaneous electrical nerve stimulation) unit with identical stimulation frequency, but potentially different amplitudes depending on the subject's stimulation threshold.</description>
    <arm_group_label>Posterior Tibial Nerve Stimulation Group</arm_group_label>
    <arm_group_label>Dorsal Genital Nerve Stimulation Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult women ≥ 18 years of age

          -  Sexually active ≥ 1 time per month (≥ 2 times per month preferred)

          -  Score of 19 or less on a 6-question set of the Female Sexual Function Index (FSFI)
             survey

          -  Neurologically stable

          -  Ambulatory

          -  Capable of giving informed consent

          -  English speaking

          -  Capable and willing to follow study procedures

        Exclusion Criteria:

          -  Men

          -  Women ≤ 17 years of age

          -  Pregnant or planning to get pregnant during the study period

          -  Clinically diagnosed neurological bladder dysfunction

          -  Prior experience with PTNS or DGNS

          -  Current use of transcutaneous electrical nerve stimulation (TENS) on pelvis, back, or
             legs

          -  Implanted pacemaker, defibrillator, spinal cord stimulator, or sacral root stimulator

          -  Taking flibanserin

          -  Taking any investigational drug

          -  History of neurologic diseases or impairments

          -  Any other factors that the investigators feel would place the patient at increased
             risk from this study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy Bruns, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mitchell Berger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Timothy Bruns, PhD</last_name>
    <email>bruns@umich.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nicole Honey</last_name>
    <phone>(734) 763-8048</phone>
    <email>nichoney@med.umich.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Michigan Health System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Timothy Bruns, PhD</last_name>
      <email>bruns@umich.edu</email>
    </contact>
    <contact_backup>
      <last_name>Nicole Honey</last_name>
      <phone>(734) 763-8048</phone>
      <email>nichoney@med.umich.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 9, 2016</lastchanged_date>
  <firstreceived_date>February 23, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Timothy Bruns</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>hypoactive desire disorder</keyword>
  <keyword>female sexual dysfunction</keyword>
  <keyword>genital arousal disorder</keyword>
  <keyword>sexual</keyword>
  <keyword>dysfunction</keyword>
  <keyword>female</keyword>
  <keyword>arousal</keyword>
  <keyword>electrical stimulation</keyword>
  <keyword>transcutaneous electrical stimulation</keyword>
  <keyword>women</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
